http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100856745-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D411-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 2002-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100856745-B1 |
| titleOfInvention | Oxazolidinone derivatives comprising a pyridine in which a hetero ring and a heteroaromatic ring are substituted or fused, and a preparation method thereof |
| abstract | The present invention relates to an oxazolidinone derivative including a pyridine in which a hetero ring and a heteroaromatic ring are substituted or fused, a method for preparing the same, and a pharmaceutical composition comprising the same, wherein the oxazolidinone derivative of Formula 1 includes Gram-positive bacteria and Gram. It shows excellent antibacterial activity against negative bacteria and its low toxicity can be used as an antibiotic.n n n Formula 1n n n n n n n n Wherein R 1 , R 2 and R 3 is as described in the specification.) n n n Oxazolidinone, pyridine, pharmaceutical composition. |
| priorityDate | 2002-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.